4,809
Views
14
CrossRef citations to date
0
Altmetric
Review Articles

The broad-spectrum antiviral recommendations for drug discovery against COVID-19

ORCID Icon, , , , ORCID Icon, , , , ORCID Icon, & show all
Pages 408-424 | Received 06 Apr 2020, Accepted 11 May 2020, Published online: 17 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Elif Caliskan Salihi & Emine Ceren Tulay. (2022) Adsorptive removal of antipsychotic drug by carbon nanofibers in a batch and fixed bed column system. Particulate Science and Technology 40:7, pages 899-910.
Read now
Ran Chen, Tingting Wang, Jie Song, Daojun Pu, Dan He, Jianjun Li, Jie Yang, Kailing Li, Cailing Zhong & Jingqing Zhang. (2021) Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics. International Journal of Nanomedicine 16, pages 4959-4984.
Read now

Articles from other publishers (12)

Ghassan Mudher Hashim, Ghaidaa S. Hameed & Dalya Basil Hanna. (2023) The possible techniques that used to improve the bioavailablity, pharmacological activity, solubility and permeability of anti-viral drugs: Insight for COVID-19 antiviral drugs. Al Mustansiriyah Journal of Pharmaceutical Sciences 23:3, pages 231-249.
Crossref
Edgar Clyde R. Lopez. (2023) De Novo Drug Design of Potential Inhibitors of SARS-CoV-2 Papain-like Protease. De Novo Drug Design of Potential Inhibitors of SARS-CoV-2 Papain-like Protease.
Qilin Wu, Chang Wang, Qinlong Jing, Jianyun Lu, Boheng Liang, Lan Liu, Jinyi Wu, Qing Yu, Xilong Deng & Zhoubin Zhang. (2022) Follow-up of patients with COVID-19 by the Delta variant after hospital discharge in Guangzhou, Guandong, China. Revista do Instituto de Medicina Tropical de São Paulo 64.
Crossref
Yong Xu, Wenpan Peng, Di Han, Zhichao Wang, Fanchao Feng, Xianmei Zhou & Qi Wu. (2021) Material Basis and Mechanism of Chansu Injection for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking Technology. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-11.
Crossref
Onur Dogan, Sanju Tiwari, M. A. Jabbar & Shankru Guggari. (2021) A systematic review on AI/ML approaches against COVID-19 outbreak. Complex & Intelligent Systems 7:5, pages 2655-2678.
Crossref
Monic Andrew & Gurunathan Jayaraman. (2021) Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19). Carbohydrate Research 505, pages 108326.
Crossref
Qiqi CaiFei YinLiming HaoWenhua Jiang. (2021) Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19. Stem Cells and Development 30:9, pages 459-472.
Crossref
Ammara Batool, Abu Hazafa, Saeed Ahmad, Hamid Ali Khan, Hafiz M.Z. Abideen, Ayesha Zafar, Muhammad Bilal & Hafiz M.N. Iqbal. (2021) Treatment of lymphomas via regulating the Signal transduction pathways by natural therapeutic approaches: A review. Leukemia Research 104, pages 106554.
Crossref
Sameena Mehtab, Pragati Joshi, M. G. H. Zaidi, T. I. Siddiqui & Vivek K. Mishra. (2021) COVID-19: Challenges, Preventive Measures and Remediation. Oriental Journal Of Chemistry 37:2, pages 285-294.
Crossref
Marcelle Moura Silveira, Gustavo Marçal Schmidt Garcia Moreira & Marcelo Mendonça. (2021) DNA vaccines against COVID-19: Perspectives and challenges. Life Sciences 267, pages 118919.
Crossref
Suresh Kumar. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses 213 230 .
Sundas Nasir Chaudhry, Abu Hazafa, Muhummad Mumtaz, Ume Kalsoom, Saima Abbas, Amna Kainaat, Shahid Bilal, Nauman Zafar, Aleena Siddique & Ayesha Zafar. (2020) New insights on possible vaccine development against SARS-CoV-2. Life Sciences 260, pages 118421.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.